Introduction
Protein kinase C (PKC) is composed of a family of serine/threonine kinases. To date, 11 dierent PKC isoenzymes belonging to three subgroups have been identi®ed (Ohno et al., 1991) . The conventional PKCs (cPKCs) comprise PKC-a, -bI, bII, and -g, and their activation is dependent on diacylglycerol, phosphoatidylserine, and calcium. The novel PKCs (nPKCs) consist of PKC-d, -e, -y, and -Z and they are activated independently of calcium. The atypical PKCs (aPKCs), PKC-l and -z, have only one of the two cysteine-rich motifs in the C1 domain. More recently, PKC-m or PKD has been cloned that contains a speci®c transmembrane domain which diers from the all other PKC family members (Johannes et al., 1994; Valverde et al., 1994) . While C1 domains of all cPKCs and nPKCs respond to 12-O-tetradecanoylphorbol-13-acetate (TPA) or diacylglycerol for binding and activation, potential ligands for aPKCs and the mechanism of their subsequent activation remain elusive. Activation of PKC is involved in many signaling transduction pathways, including cell growth, dierentiation, and malignant transformation (Nishizuka, 1992) . Although one cell line or tissue often expresses several various PKC isoenzymes, dierent PKCs must exert distinct functions. For example, PKC-a and -d, but not -bI, -e, -Z and -z have recently been shown to mediate monocytic dierentiation in response to TPA stimulation when overexpressed in 32D myeloid progenitor cells (Mischak et al., 1993) .
Apoptosis is the process of cells undergoing programmed cell death and it has been linked to physiological and pathological conditions, such as death of T lymphocytes in thymus (Fairbairn et al., 1993; Peter et al., 1997; Saini and Walker, 1998) . To date, dierent genes including Bcl-2 family members, caspases, and other signaling pathways have been implicated in apoptosis (Cory, 1995; Korsmeyer, 1995) . Several reports indicate that dierent PKCs are also involved in apoptotic signaling pathways (Barr et al., 1997; Berra et al., 1997; Datta et al., 1997; DiazMeco et al., 1996; Emoto et al., 1995 Emoto et al., , 1996 Ghayur et al., 1996; Mizuno et al., 1997; Whelan and Parker, 1998; Whitman et al., 1997) . When U937 cells were exposed to ionizing radiation, TNF-a or anti-Fas antibody, cells underwent apoptosis (Emoto et al., 1995) . Interestingly, a phosphoprotein of 40 kDa was detected after treatment of U937 cells with ionizing radiation. This protein was determined to be the catalytic domain of PKC-d that was generated by cleaving the hinge region sequence at a DMQD/N site through activated caspase-3. Apoptosis was also induced by expressing the catalytic domain of PKC-d directly in several cell lines, including NIH3T3, HeLa, and COS-1 cells (Ghayur et al., 1996) . These results indicate that activation of PKC-d plays an important role in DNA damaging agent-induced apoptosis. More recently, activation of a protease (CPP32-like) leading to degradation of various PKC isoenzymes, including PKC-d, -y, and -e in response to DNA damaging reagents has been reported (Mizuno et al., 1997) . These data suggest that activation of nPKCs by protease cleavage may allow these PKC isoenzymes to exert pro-apoptotic eects. In contrast, PKC-bII was demonstrated to be critical in antagonizing Ara-Cinduced apoptosis in the HL-60 acute myelogenous leukemia line (Whitman et al., 1997) and in inhibiting c-myc-induced apoptosis of small cell lung cancer cells (Barr et al., 1997) .
Akt, also known as PKB and Raca, was originally cloned from a T cell lymphoma (Bellacosa et al., 1991; Jones et al., 1991) . It contains homology to both protein kinase A and PKC in its catalytic domain and has a pleckstrin homology (PH) domain at its Nterminus. Stimulation of the phosphoinositol 3' kinase (PI 3'K) pathway was demonstrated to be necessary for Akt activation in most instances (Burgering and Coer, 1995; Datta et al., 1995; Franke et al., 1995) . The importance of Akt in protecting cell from apoptosis was suggested in PC12 neuronal cells depleted of nerve growth factor and in ®broblast and epithelial cells in response to UV radiation (Ahmed et al., 1997; Eves et al., 1998; Kaumann-Zeh et al., 1997; Kennedy et al., 1997) .
In the present study, we analysed the eects of overexpressing PKC-a, -d, and -e in apoptosis that was induced by interleukin 3 (IL-3) withdrawal in 32D cells. All three PKC isoenzymes are endogenously expressed at low levels in 32D cells (Li et al., 1995; Mischak et al., 1993) . Our results demonstrate that overexpression of PKC-a, but not -d or -e, signi®cantly suppressed the onset of apoptosis by cytokine withdrawal. Anti-apoptotic eect of PKC-a correlated with its ability to activate Akt in vivo.
Results

Overexpression of PKC-a in 32D cells delays the onset of apoptosis
To investigate the role of dierent PKC isoenzymes in apoptosis induced by IL-3 withdrawal, we overexpressed various PKCs (PKC-a, -d, and -e) in the IL-3-dependent 32D myeloid progenitor cells and examined apoptosis by genomic DNA fragmentation and¯ow cytometric analyses. A signi®cant increase in the level of the corresponding PKC was detected in the PKC transfectants (see Figure 4b ). DNA fragmentation was detected as early as 12 h after IL-3 withdrawal in the 32D/vector transfectants and was evident 24 h after IL-3 removal (Figure 1a ). In contrast, no DNA fragmentation was observed in samples obtained 12 and 24 h after IL-3 deprivation in the 32D/PKC-a transfectants. Although overexpression of PKC-a suppressed apoptosis in 32D cells, overexpression of PKC-d or -e did not inhibit cell death (Figure 1b) . Consistent with previous result (Fairbairn et al., 1993) , overexpression of Bcl-2 greatly inhibited DNA fragmentation (Figure 1a,b) . As expected, growth of 32D cells in IL-3 protected cells from apoptosis ( Figure 1b) .
Determination of cell populations localized in sub-G1 peak in¯ow cytometric analysis using PI staining is another indicator of apoptosis. As shown in Figure 6b , IL-3 withdrawal from 32D cells for 18 h resulted in 21% of cells in sub-G1. In agreement with the DNA fragmentation result (Figure 1) , the sub-G1 phase population of 32D/PKC-a cells accounted for only 12% of total cell population (Figure 6d ). Overexpression of PKC-d or -e did not alter the percentage of cells in the sub-G1 phase after IL-3 withdrawal when compared to 32D/vector transfectants (data not shown). Taken together, our results demonstrate that PKC-a selectively inhibits 32D cell apoptosis after IL-3 withdrawal.
Endogenous Akt activity is greatly enhanced in 32D/ PKC-a transfectants Recently, Akt activation in response to IL-3 stimulation was reported (Songyang et al., 1997) . We attempted to correlate PKC-a suppression of apoptosis with the Akt activation. As shown in Figure 2a ,b, overexpression of PKC-a increased endogenous Akt activity by 1.9, 2.3, 2.0 and 2.1-fold in four PKC-a Figure 1 Overexpression of PKC-a but not -d or -e suppresses genomic DNA fragmentation induced by IL-3 withdrawal. 32D cells and various transfectants were maintained in media without IL-3 for various time periods. Genomic DNA was isolated using a kit from Boehringer Mannheim Biochem. Ten mg of genomic DNA from the following cell lines were separated on a 2% agarose gel to analyse for DNA fragmentation. (a) 32D/vector, 32D/PKC-a and 32D/Bcl-2 transfectants. (b) 32D cells, 32D/ PKC-a, -d, and -e transfectants, 32D cells cultured in the presence of IL-3, and 32D/Bcl-2 transfectants. DNA markers are given in base pairs transfectants, as designated 32D/PKC-a.1, PKC-a.2, PKC-a.3, and PKC-a.4, respectively, for basal Akt activity. In contrast, overexpression of PKC-d or -e did not increase Akt activity (Figure 2a,b) . When endogenous Akt protein levels were measured by anti-Akt immunoblot analysis, no increase in Akt protein levels was detected in PKC-a transfectants when compared to control cells (Figure 2c,d ). Endogenous Akt migrated as a doublet in IL-3 starved 32D cells. The mobility of the Akt protein was shifted in response to IL-3 stimulation (Figure 2c, d) , re¯ecting the serine/threonine phosphorylation of Akt (Alessi et al., 1996; Stokoe et al., 1997) . Interestingly, some 32D/PKC-a transfectants, such as 32D/PKC-a.2, showed a shift in mobility even in the absence of IL-3. In contrast, no shift in Akt was observed in 32D/PKC-e transfectants in spite of IL-3 stimulation. Since phosphorylation of Akt is required for its activation (Alessi et al., 1996; Stokoe et al., 1997) , the Akt mobility shifting data support the observed increase in Akt activity by PKC-a overexpression. Furthermore, these results suggest that inhibition of apoptosis by PKC-a could correlate with its eect on Akt activity.
PKC-a increases exogenous Akt activity upon Akt overexpression in vitro
To further demonstrate the speci®c induction of Akt activity by PKC-a, we coexpressed PKC-a together with wild type HA-Akt (PKC-a/AktWT). An ATP binding mutant of Akt (AktKM), which had been previously shown to be kinase inactive (Songyang et al., 1997) , was also coexpressed with PKC-a (PKC-a/ AktKM). As shown in Figure 3a , expression of AktWT resulted in IL-3-dependent activation of Akt. Coexpression of PKC-a with AktWT led to a 1.2-fold increase in basal Akt activity compared to that of AktWT alone. IL-3 stimulation caused 1.5-fold more Akt activity from 32D/PKC-a/AktWT transfectants when compared to that of 32D/AktWT alone. Overexpression of the AktKM mutant alone or together with PKC-a did not signi®cantly increase Akt activity when compared with the parental line, indicating that the increased Akt activity mediated by PKC-a requires an active Akt protein. These results also suggest that Akt, not other co-immunoprecipitated kinases, was responsible for PKC-a-enhanced Akt phosphorylation of the substrate. Subsequent immunoblotting the membrane from Figure 3a with anti-Akt serum indicated that AktWT protein levels of 32D/AktWT line were higher than that of 32D/PKC-a/AktWT (Figure 3b ). This excluded any possibilities that increased Akt phosphorylation of the substrate by PKC-a coexpression was due to the higher Akt protein levels in 32D/PKC-a/AktWT transfectants. By normalizing for Akt protein levels from dierent transfectants, we conclude that overexpression of PKC-a caused 2.5 and 3.3-fold increases of exogenous Akt activities under basal and IL-3 stimulated conditions, respectively.
Exogenous Akt activity is only increased upon PKC-a, but not PKC-d or -e overexpression
To con®rm our observation that only PKC-a, but not PKC-d or -e overexpression led to increased endogenous Akt activity (see Figure 2) , we chose to transfect Figure 2 Endogenous Akt activity is enhanced by PKC-a but not -d or -e overexpression. (a,b) 32D cells and transfectants were deprived of IL-3 for 2 h and lysed. Endogenous Akt activity from anti-Akt immunoprecipitates was measured using Histone H2B as a substrate. Phosphorylated H2B is marked in both panels. (c,d) The same transfectants were deprived of IL-3 for 2 h and either untreated or stimulated with IL-3 for 10 min. Equivalent amounts of proteins (50 mg per lane) were subjected to SDS ± PAGE and immunoblotted (Blot) with anti-Akt antibody. The Akt doublets are marked by arrows the various PKC cDNAs into a 32D/AktWT line. 32D cells endogenously express these three PKC isoenzymes (Li et al., 1995; Mischak et al., 1993) . Upon transfection, the corresponding PKC protein levels were increased as detected by speci®c anti PKC antibodies (Figure 4b ). When the PKC/Akt cotransfectants were subjected to an Akt activity assay, no signi®cant increase of Akt activity was observed from PKC-d/AktWT and PKC-e/AktWT contransfectants when compared to that of 32D/Akt alone either in untreated or in IL-3 stimulated condition (Figure 4a ). In contrast, PKC-a/AktWT transfectants possessed twofold more Akt activity than AktWT in response to IL-3 treatment. More importantly, the basal Akt activity from the representative PKC-a/AktWT transfectants was much higher than any other lines tested (Figure 4a ). The constitutive activation of endogenous (Figure 2a, b) and overexpressed Akt (Figures 3a and  4a ) by PKC-a in the absence of IL-3 supports the idea that PKC-a participates in the activation of Akt, which may contribute to the anti-apoptotic potential of PKCa.
Wortmannin partially inhibits PKC-a-induced Akt activation
It has been reported that two products of PI 3'K, 3, 4, 5 phosphoinosite triphosphate and 3, 4 phosphoinosite biphosphate, bind to the PH domain of Akt. This binding subsequently induces the translocation of Akt from the cytosol to the plasma membrane where it is activated through phosphorylation (Alessi et al., 1996; Franke et al., 1997; Hemming, 1997; Stokoe et al., 1997; Vanhaesebroeck et al., 1997) . In order to test whether PKC-a activates Akt through PI 3'K activation, we performed the Akt activity assay in the presence of a speci®c PI 3'K inhibitor, wortmannin. As seen in Figure 5a , IL-3 stimulation of AktWT transfectants resulted in Akt activation. This activation was inhibited by the addition of wortmannin, indicating that IL-3-induced Akt activation requires PI 3'K. Surprisingly, addition of TPA with IL-3 also suppressed IL-3-induced Akt activity. When PKC-a/ AktWT transfectants were exposed to wortmannin in the presence of IL-3, similar inhibition of Akt activity was observed. Wortmannin alone partially inhibited Akt activity in the same transfectants, suggesting that PKC-a-mediated Akt activation is partially dependent on PI 3'K. Again, TPA suppressed IL-3-induced Akt activation in PKC-a/AktWT cotransfectants.
PKC-a overexpression increases phosphorylation of serine (Ser) 473 on Akt
Recently, two important phosphorylation sites, Ser 473 and Thr 308, have been mapped on Akt in response to growth factor stimulation. Phosphorylation on these two sites correlates with the increased Akt activity (Alessi et al., 1996) . Thus, we examined the phosphorylation status of Ser 473 by immunoprecipitating cell lysates with anti-HA antibody followed by anti-P-Ser 473 immunoblot analysis (Figure 5b ). While anti-P-Ser 473 did not detect any phosphorylation of endogenous Akt due to anti-HA immunoprecipitation, overexpression of HA-AktWT resulted in some basal phosphorylation. This phosphorylation was increased by 2.5-fold in response to IL-3 stimulation. The basal and IL-3-induced Ser 473 phosphorylation was increased by 1.9-and 1.4-fold, respectively, in PKC-a/AktWT cotransfectants. In contrast, coexpression of either PKC-d or PKC-e with AktWT did not increase Ser 473 phosphorylation when compared to those of AktWT transfectants, further substantiating the previous results that only PKC-a is able to stimulate Akt activity. Similar expression levels of HA-Akt were detected in all the transfectants (data not shown).
Time course experiment was subsequently performed to detect the maximal phosphorylation of Ser 473 in both AktWT and PKC-a/AktWT transfectants. As shown in Figure 5c , the maximal phosphorylation of Akt on Ser 473 in AktWT transfectants occurred 10 min after IL-3 stimulation, whereas coexpression of PKC-a with AktWT induced the maximal phosphorylation 1 min post stimulation. Addition of wortmannin to AktWT and PKC-a/AktWT transfectants inhibited both IL-3-induced and basal Akt phosphorylation on Ser 473, consistent with its eect on H2B phosphorylation (see Figure 5a) . Together, our results demonstrate that PKC-a-induced Akt activity correlates with Ser 473 phosphorylation and is partially dependent on PI 3'K.
PKC-a cooperates with Akt in protecting 32D cells from apoptosis
Having demonstrated that PKC-a was able to suppress apoptosis and to activate both endogenous and overexpressed Akt, we then determined if coexpression of Akt with PKC-a would further enhance the antiapoptotic eect exerted by PKC-a alone. Thus,¯ow cytometric analysis was performed to detect apoptotic cell populations. As shown in Figure 6a , no apoptotic cells were detected in the sub-G1 peak when 32D cells were cultured in the presence of IL-3. Approximately 50% of cells were in S phase and 23% in G2/M phase (Figure 6a ), indicating that IL-3 stimulates DNA synthesis and cell division of 32D cells. In contrast, 21% of the 32D cells were detected in the sub-G1 phase when deprived of IL-3 for 18 h (Figure 6b ). Addition of wortmannin to 32D cells in the absence of IL-3 did not further increase the apoptotic population (Figure 6c , sub-G1 peak 23%), indicating that the dose of wortmannin was not toxic to the cells analysed. As expected, overexpression of PKC-a suppressed sub-G1 population by almost 50% when IL-3 was not included in the medium (Figure 6d ). This suppression was weakly reversed by wortmannin (Figure 6d,e) . Overexpression of HA-Akt alone did not protect cells from apoptosis ( Figure 6f ) and suppression of PI 3'K by wortmannin had no eect on apoptosis in these transfectants (Figure 6g) . Interestingly, coexpression of PKC-a together with Akt almost completely blocked the onset of apoptosis induced by IL-3 withdrawal (Figure 6h) . Consistent with the results of wortmannin in inhibiting Akt activity and Ser 473 phosphorylation in PKC-a/AktWT transfectants, treatment with wortmannin partially increased the sub-G1 population (Figure 6i , from 3 to 8%). Taken together, these results suggest that PKC-a can cooperate with overexpressed Akt to further suppress apoptosis induced by IL-3 withdrawal. The cooperative eect of PKC-a and Akt on suppression of apoptosis correlates with the enhanced basal Akt activity observed when both molecules were coexpressed (see Figures 3 and 4) . (a) 32D cells and transfectants were serum and IL-3 starved for 2 h and either untreated or stimulated with IL-3 for 10 min. If wortmannin (1 mM, abbreviated as`wort' in the ®gure) was included, it was added to the transfectants 20 min prior to IL-3 stimulation. TPA (100 ng/ml) was added simultaneously with IL-3. Equivalent amounts of cell lysates were immunoprecipitated (IP) with anti-HA followed by an Akt activity assay. The kinase reaction was separated by SDS ± PAGE and transferred proteins on Immobilon were detected by autoradiography. Phosphorylated Histone H2B is marked. (b) 32D cells and transfectants were serum and IL-3 starved for 2 h and either untreated or stimulated with IL-3 for 10 min. Equivalent amounts of cell lysates were immunoprecipitated by anti-HA antibody. Proteins were separated by 8% SDS ± PAGE and transferred proteins were immunoblotted with anti-P-S473Akt antibody. (c) Starved cells were either untreated or stimulated with IL-3 for dierent time as indicated. Wortmannin was similarly used as in a. Phospho-Akt is marked undergo DNA synthesis in the absence of IL-3. Together, our results suggest that overexpression of PKC-a delays the onset of apoptosis and coexpression of PKC-a with Akt further enhances this eect as determined by both¯ow cytometric analysis and [ 3 H]-TdR incorporation assay.
Discussion
In the present study, we provide evidence that overexpression of PKC-a suppresses the apoptosis of 32D cells induced by IL-3 withdrawal. The antiapoptotic role exerted by PKC-a was speci®c, since overexpression of PKC-d or -e in the same cell background did not protect transfectants from apoptosis. Our results indicate that individual PKC isoenzymes, exempli®ed in this study by PKC-a, -d and -e which are all expressed endogenously in 32D cells, possess dierent functions in the same tissue or cell.
While overexpression of PKC-a and -d allowed TPA to induce monocytic dierentiation of 32D cells (Mischak et al., 1993) , only PKC-a was able to protect 32D cells from apoptosis. The eect of apoptotic suppression by PKC-a correlated well with Akt activation and this activation was only observed after PKC-a, but not PKC-d or -e overexpression. On the other hand, Bcl-2 gene expression was not speci®cally aected by overexpression of dierent PKCs (W Li, unpublished observation). To support our hypothesis, we could show that coexpression of PKC-a with Akt increased the anti-apoptotic eect of PKC-a. Furthermore, these cotransfectants were able to undergo short-term DNA synthesis.
The anti-apoptotic eect exerted by PKC-a was also recently observed by Parker's group (Whelan and Parker, 1998) . When COS-1 cells were transfected with a dominant negative mutant of PKC-a, apoptosis was induced. Coexpression of wild type of PKC-a with the mutant rescued these cells from apoptosis. We had Figure 6 Overexpressed Akt cooperates with PKC-a to suppress apoptosis induced by IL-3 withdrawal. 32D cells and transfectants were maintained either in the presence (a, 32D cells) or the absence of IL-3 (b ± i) for 18 h with or without 1 mM of wortmannin. The cells were stained with PI and subjected to¯ow cytometric analysis. The sub-G1 peaks are marked by arrows and the percentage of cells localized in the sub-G1 peaks is shown in numbers in the upper right portion of each graph some diculties in expressing an ATP binding mutant of PKC-a stably in 32D cells to analyse its eect on Akt activation (W Li, unpublished observation), which may be due to the induction of apoptosis by this mutant. Although the anti-apoptotic eect by PKC-a was detected at overexpression in our system, a physiological role of PKC-a in suppressing apoptosis induced by ionizing radiation in human leukemia TF-1 line has recently been reported (Kelly et al., 1998) . Activation and upregulation of PKC-a were demonstrated in many androgen-independent prostate cancer cells and PKC-a activation is likely to suppress apoptosis induced by radiation and chemical therapy against these cancer cells. Accordingly, new therapeutic strategies employing anti-sense oligonucleotides of PKC-a and dominant negative PKC-a to treat prostate cancer patients have been recently proposed (O'Brian, 1998) .
The mechanism(s) underlying the role of PKC-a activation of Akt is not fully understood. Supernatant from PKC-a transfectants did not enhance Akt activity, excluding the possibility of autocrine mechanism for PKC-a activation of Akt (W Li, unpublished observation). The partial reversion of PKC-a-dependent Akt activity and PKC-a anti-apoptotic eect by wortmannin suggests that PI 3'K may be involved in this process. On the other hand, activation of PKC-a by TPA stimulation inhibited IL-3-stimulated Akt activity in PKC-a /AktWT transfectants. Since TPA also inhibited IL-3-induced Akt activity in 32D cells expressing Akt alone (see Figure 5a ), these results suggest that TPA may stimulate an inhibitory eect on Akt activation in 32D cells, which antagonizes its direct activation of PKC-a. When PKC-a was coexpressed with Akt in COS-7 cells, stimulation of Akt activity by TPA was detected in PKC-a/Akt cotransfectants (W Li, unpublished observation).
Akt activation is dependent on plasma membrane localization (Alessi et al., 1996; Andjelkovic et al., 1997) and subsequent phosphorylation on Thr 308 and Ser 473 (Alessi et al., 1996; Andjelkovic et al., 1997; Downward, 1998; Pullen et al., 1998; Stephens et al., 1998) . Recently, PDK1 responsible for Akt Thr 308 phosphorylation has been cloned, and it contains PH domain at its carboxyl terminus (Stephens et al., 1998) . Interestingly, the consensus sequence around Thr 308 (T 308 FCGT) of Akt is fully conserved in the PKC-a activation loop, corresponding to Thr 497 of PKC-a (Pullen et al., 1998) . Recently, PDK1 was demonstrated to phosphorylate activation loops of PKC-d and -z in vivo in a PI 3'K-dependent manner (Le Good et al., 1998) . Phosphorylation of these PKCs by PDK1 subsequently enhanced their kinase activities. Thus, one could speculate that PKC-a is phosphorylated on the activation loop and activated by PDK1 or other mechanism(s). Activated PKC-a may further cooperate with PDK1 to fully activate Akt by phosphorylating it at dierent sites. Demonstration of increased phosphorylation of Akt on Ser 473 by PKC-a overexpression fully supports this notion.
Whether the Akt pathway is the only one downstream of PKC-a activation that is involved in the suppression of apoptosis remains to be determined. Our preliminary results indicate that overexpression of an ATP binding mutant of Akt (KM) into PKC-a cells did not aect the survival of the transfectants (W Li, unpublished observation). On the other hand, coexpression of PKC-a with wild type Akt did enhance the cell survival rate and induce more potent short-term [ 3 H]TdR incorporation when compared to 32D/PKC-a transfectants (see Figures 6 and 7) . Together, these data suggest PKC-a may utilize multiple signaling pathways, which cooperate with Akt to mediate the suppression of apoptosis. Currently, we are testing whether phosphorylation of BAD (del Peso et al., 1997), a member of Bcl-2 family, by Akt is altered in PKC-a transfectants. In addition, identi®cation of other phosphorylated proteins in 32D/PKC-a/Akt transfectants is under way in order to further seek insight into the downstream signaling pathways activated by PKC-a and Akt.
In summary, our results demonstrate that overexpression of PKC-a in 32D myeloid cells renders these transfectants more resistant to apoptosis. This eect is only exerted by PKC-a, but not -d or -e, indicating a speci®c role of PKC-a in blocking apoptosis induced by cytokine withdrawal. Detection of Akt activation by PKC-a should allow for the investigation of potential cross talk between PKC and Akt in dierent biological systems.
Materials and methods
Cell culture and transfection
32D cells and transfectants were routinely maintained in RPMI 1640 containing 15% fetal calf serum (FCS) and 5% conditioned supernatant from WEHI 3B line as a source of IL-3. Transfection of 32D cells with dierent PKC isoenzymes cloned in pLTR vector using electroporation Figure 7 Coexpression of PKC-a with Akt allows these transfectants to undergo DNA synthesis in the absence of IL-3. 32D cells and the various transfectants were deprived of IL-3 and maintained in RPMI 1640 containing 15% FCS for 44 h. [ was described previously (Li et al., 1995; Mischak et al., 1993) . pBabe vector containing hemagglutinin (HA)-tagged wild type Akt (AktWT) or an ATP binding mutant (AktKM) (Songyang et al., 1997) was also transfected into 32D cells by electroporation.
Genomic DNA fragmentation assay
A kit from Boehringer Mannheim was used for the preparation of genomic DNA (Apoptotic DNA-ladder kit, 1835246). Brie¯y, 32D cells and transfectants were washed and maintained in media without IL-3 for dierent time periods at a concentration of 1610 6 cells/ml. Genomic DNA was isolated using the resin column supplied by the kit. Ten mg of genomic DNA were loaded on 2% agarose gel in the presence of ethidium bromide, and the gel was photographed using Eagle Eye (Stratagene).
Detection of apoptotic cells and¯ow cytometric analysis using propidium iodide (PI) staining IL-3 was withdrawn from 32D cells and transfectants for 18 h and ®xed with 70% ethanol. The ®xed cells were stained with 50 mg/ml of PI (CalBiocem) in the presence of 500 mg/ml of RNase A for 30 min on ice. The stained cells were ®ltered through 35 mM nylon mesh and subjected to¯ow cytometric analysis using a FACSCalibur from Becton Dickinson. Wortmannin (Sigma, 1 mM) was also included where indicated.
In vitro Akt activity assay using Histone H2B as a substrate
The method used for measuring Akt activity in vitro has been reported elsewhere . Brie¯y, 32D cells and transfectants were washed and maintained in serum-free medium for 2 h and were either untreated or stimulated with IL-3 (100 ng/ml) for 10 min at 378C. Wortmannin was added 20 min prior to IL-3 stimulation. Cells were lysed in a lysis buer as reported (Li et al., 1994) and equivalent amounts of cell lysates were immunoprecipitated with either anti-Akt serum (Songyang et al., 1997 ) (for endogenous Akt activity assay, 1 : 1000 dilution) or anti-HA (2 mg per sample, Boehringer Mannheim). Washed immunoprecipitates were incubated in 30 ml reaction mixture containing 20 mM HEPES, pH 7.4, 10 mM MgCl 2 , 10 mM MnCl 2 , 10 mCi [g-32 P]ATP, 5 mM cold ATP, 1 mM DTT and 3 mg of Histone H2B (Boehringer Mannheim) for 20 min at room temperature. The reaction was stopped by adding 30 ml of 26sample buer and separated by 12% sodium dodecyl sulfatepolyacrylamide gel electrophoresis (SDS ± PAGE). Proteins separated by SDS ± PAGE were transferred to Immobilon ®lters and detected by autoradiography. To determine the expression levels of Akt in dierent transfectants, the Immobilon ®lter was subsequently immunoblotted with anti-Akt serum (1 : 1000 dilution) and developed using the ECL detection system (Amersham). Anti-P-Ser 473 serum (1 : 1000 dilution, New England Biolab) was used in immunoblot analyses to detect phosphorylated Akt on Ser 473. The intensities of protein bands derived from ECL and in vitro kinase assays were quanti®ed using the scan analysis program from Biosoft. Transfectants of 32D cells and the parental line were washed twice with D-PBS and the number of cells were determined using an automatic cell counter (Coulter). 2610 5 cells were plated into each well of the 24-well plates in RPMI1640 media containing 15% FCS without IL-3. After 44 h in culture, the cells were pulsed with 1 mCi of [ 3 H]TdR (Amersham) for another 4 h, and harvested using a cell harvester (Skatron). Dried ®lters were soaked into scintillation liquid and the c.p.m. was measured using a beta counter (Bekmann, LS6500).
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